PBPIA
Pivotal bioVenture Partners Investment Advisor Portfolio holdings
AUM
$161M
This Quarter Return
+23.32%
1 Year Return
+58.57%
3 Year Return
+760.98%
5 Year Return
–
10 Year Return
–
AUM
$243M
AUM Growth
+$243M
(+5.6%)
Cap. Flow
+$23.8M
Cap. Flow
% of AUM
9.79%
Top 10 Holdings %
Top 10 Hldgs %
99.73%
Holding
11
New
1
Increased
2
Reduced
1
Closed
–
Top Buys
| 1 |
Oculis Holding
OCS
|
$17.7M |
| 2 |
INZY
Inozyme Pharma
INZY
|
$3.17M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$2.93M |
Top Sells
| 1 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
$8 |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
KRTX
1
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $142M | 58.49% | 782,008 +16,113 | +2% | +$2.93M |
|
2
Vaxcyte
PCVX
$4B
| $26M | 10.7% | 693,039 | – | – |
|
|
INZY
3
DELISTED
Inozyme Pharma
INZY
| $18.4M | 7.58% | 3,213,586 +552,432 | +21% | +$3.17M |
|
|
4
Oculis Holding
OCS
$844M
| $17.7M | 7.29% | +2,381,196 | New | +$17.7M |
|
5
Rallybio
RLYB
$22.4M
| $13.7M | 5.65% | 2,404,644 | – | – |
|
6
Arcutis Biotherapeutics
ARQT
$1.86B
| $6.26M | 2.58% | 569,041 | – | – |
|
|
FUSN
7
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $5.88M | 2.42% | 1,560,982 -2 | -0% | -$8 |
|
|
VIGL
8
DELISTED
Vigil Neuroscience
VIGL
| $5.49M | 2.26% | 560,595 | – | – |
|
|
EXAI
9
DELISTED
Exscientia Plc American Depositary Shares
EXAI
| $4.09M | 1.69% | 772,285 | – | – |
|
10
Bolt Biotherapeutics
BOLT
$9.85M
| $2.63M | 1.08% | 1,891,467 | – | – |
|
11
Aligos Therapeutics
ALGS
$73.3M
| $650K | 0.27% | 743,215 | – | – |
|